Evidence map›Paper›PMID 41753729›Full record

ArticleMicroorganisms2026

Remdesivir: Real-World Effectiveness and Safety in Individuals Hospitalized for Non-COVID Reasons and Non-Hospitalized High-Risk Patients During the Omicron Era in Greece.

Nikos Pantazis, Spyridon Kontos, Evmorfia Pechlivanidou, Nikolaos V Sipsas, Diamantis Kofteridis, Periklis Panagopoulos, Vassiliki Rapti, Symeon Metallidis, Karolina Akinosoglou, Dimitra Kavatha and 16 more

Abstract read
In one paragraph

Article in Microorganisms, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

26 authors.

Nikos PantazisDepartment of Hygiene, Epidemiology and Medical Statistics, Medical School, National & Kapodistrian University of Athens, 11527 Athens, Greece.ORCID 0000-0002-4196-5066
Spyridon KontosDepartment of Hygiene, Epidemiology and Medical Statistics, Medical School, National & Kapodistrian University of Athens, 11527 Athens, Greece.
Evmorfia PechlivanidouDepartment of Hygiene, Epidemiology and Medical Statistics, Medical School, National & Kapodistrian University of Athens, 11527 Athens, Greece.ORCID 0000-0002-0492-2550
Nikolaos V SipsasInfectious Diseases and COVID-19 Unit, General Hospital of Athens Laiko, Medical School, National & Kapodistrian University of Athens, 11527 Athens, Greece.ORCID 0000-0001-6955-3453
Diamantis KofteridisDepartment of Internal Medicine, University General Hospital of Heraklion, Faculty of Medicine, School of Health Sciences, University of Crete, 71003 Heraklion, Greece.ORCID 0000-0003-0255-5926
Periklis PanagopoulosDepartment of Internal Medicine, University General Hospital of Alexandroupolis, Department of Medicine, Democritus University of Thrace, 68100 Alexandroupolis, Greece.
Vassiliki Rapti3rd Department of Internal Medicine, Athens Hospital for Diseases of the Chest "Sotiria", Medical School, National & Kapodistrian University of Athens, 11527 Athens, Greece.ORCID 0000-0002-8322-635X
Symeon Metallidis1st Department of Internal Medicine, AHEPA University General Hospital, Medical School, Aristotle University of Thessaloniki, 54124 Thessaloniki, Greece.
Karolina AkinosoglouDepartment of Internal Medicine, University General Hospital of Patras, Department of Medicine, University of Patras, 26504 Rio, Greece.ORCID 0000-0002-4289-9494
Dimitra Kavatha4th Department of Internal Medicine, Attikon University General Hospital, Medical School, National & Kapodistrian University of Athens, 26504 Athens, Greece.
Haralampos MilionisDepartment of Internal Medicine, University General Hospital of Ioannina, Faculty of Medicine, Department of Internal Medicine, School of Health Sciences, University of Ioannina, 45110 Ioannina, Greece.ORCID 0000-0003-3958-2266
Ioannis Kalomenidis1st Department of Critical Care & Pulmonary Service, Evangelismos General Hospital, Medical School, National & Kapodistrian University of Athens, 11527 Athens, Greece.
Ioannis KatsarolisMedical Affairs, Gilead Sciences Hellas and Cyprus, 17564 Paleo Faliro, Greece.ORCID 0000-0002-5710-1545
Vasiliki E GeorgakopoulouInfectious Diseases and COVID-19 Unit, General Hospital of Athens Laiko, Medical School, National & Kapodistrian University of Athens, 11527 Athens, Greece.ORCID 0000-0003-0772-811X
Vasileios PetrakisDepartment of Internal Medicine, University General Hospital of Alexandroupolis, Department of Medicine, Democritus University of Thrace, 68100 Alexandroupolis, Greece.
Garyfallia Poulakou3rd Department of Internal Medicine, Athens Hospital for Diseases of the Chest "Sotiria", Medical School, National & Kapodistrian University of Athens, 11527 Athens, Greece.ORCID 0000-0003-0778-0006
Olga Tsachouridou1st Department of Internal Medicine, AHEPA University General Hospital, Medical School, Aristotle University of Thessaloniki, 54124 Thessaloniki, Greece.
Markos MarangosDepartment of Internal Medicine, University General Hospital of Patras, Department of Medicine, University of Patras, 26504 Rio, Greece.
Anastasia Antoniadou4th Department of Internal Medicine, Attikon University General Hospital, Medical School, National & Kapodistrian University of Athens, 26504 Athens, Greece.ORCID 0000-0003-0991-9198
Eleni PolyzouDepartment of Internal Medicine, University General Hospital of Patras, Department of Medicine, University of Patras, 26504 Rio, Greece.
Eleni Papantoniou1st Department of Internal Medicine, AHEPA University General Hospital, Medical School, Aristotle University of Thessaloniki, 54124 Thessaloniki, Greece.ORCID 0009-0000-1738-2832
Pinelopi Kazakou4th Department of Internal Medicine, Attikon University General Hospital, Medical School, National & Kapodistrian University of Athens, 26504 Athens, Greece.
Eirini ChristakiDepartment of Internal Medicine, University General Hospital of Ioannina, Faculty of Medicine, Department of Internal Medicine, School of Health Sciences, University of Ioannina, 45110 Ioannina, Greece.
Theofani Rimpa1st Department of Critical Care & Pulmonary Service, Evangelismos General Hospital, Medical School, National & Kapodistrian University of Athens, 11527 Athens, Greece.ORCID 0000-0002-2665-6003
Sotirios P Karagiannis1st Department of Critical Care & Pulmonary Service, Evangelismos General Hospital, Medical School, National & Kapodistrian University of Athens, 11527 Athens, Greece.ORCID 0000-0002-2823-5675
Giota TouloumiDepartment of Hygiene, Epidemiology and Medical Statistics, Medical School, National & Kapodistrian University of Athens, 11527 Athens, Greece.ORCID 0000-0002-5951-0844

Funding

Gilead Sciences, Inc. CO-GR-540-6245
6 · The paper itself

Abstract

Remdesivir is recommended for hospitalized patients with severe COVID-19 and for those at high risk of progression. Real-world Omicron-era data on incidental COVID-19 and high-risk outpatients remain limited. We conducted a multicenter retrospective cohort study (ReEs-COVID19) in Greece (June-December 2022) including adults with PCR-confirmed SARS-CoV-2 infection who received remdesivir. Hospitalized patients with incidental COVID-19 (Group A,

Indexed as

COVID-19effectivenessincidentally COVID-19-positive patientsnon-hospitalized high-risk COVID-19-positive patientsremdesivirsafety

Identifiers

PMID41753729
PMCPMC12943158

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.